Cytek Biosciences
CTKB
CTKB
74 hedge funds and large institutions have $515M invested in Cytek Biosciences in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
+22
Holders Change %
+42.31%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
29
Increased
33
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$68.5M |
| 2 |
RCM
2
RA Capital Management
Boston,
Massachusetts
|
$144M |
| 3 |
3
BlackRock
New York
|
$65.7M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$14.2M |
| 5 |
5
D.E. Shaw & Co
New York
|
$7.91M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Norges Bank
Oslo,
Norway
| – | -$546K | -33,443 | Closed |
|
|
CIP
77
Cornerstone Investment Partners
Atlanta,
Georgia
| – | -$188K | -11,500 | Closed |
|
78
Marshall Wace
London,
United Kingdom
| – | -$117K | -7,160 | Closed |
|
|
SO
79
STRS Ohio
Columbus,
Ohio
| – | -$60K | -3,700 | Closed |
|